From Patient to MIP Advocate: Bill’s Journey with Myeloma
Last Updated: January 22, 2026
Bill Wambiscus is a longtime journalist and NCODA collaborator—and in this bonus episode, he shares what it felt like to go from reporter to patient after a multiple myeloma diagnosis. He talks candidly about the realities that show up outside the clinic: oral oncolytic logistics, specialty deliveries, dose changes, and the financial uncertainty that can derail care.
Bill’s connection to NCODA started as a patient, when an NCODA member pharmacist helped secure urgent financial assistance in minutes after his support fell through mid-year. That experience later shaped his work on the updated ASCO/NCODA Standards for Oncology Pharmacy Practice.
In this episode:
- What patients experience between visits (delivery, cost, adherence stress)
- Why cycle-to-cycle changes create real medication waste and confusion
- What medically integrated pharmacy support looks like from the patient side
- How patient voice can shape standards that improve access and care
Recent Episodes
S9 E15: Theranostics: The New Era of Targeted Imaging & Therapy
Nick Mastiscusa, PharmD, discusses the evolving role of nuclear pharmacy and theranostics in cancer care, including targeted radiopharmaceutical therapies and patient safety considerations. This episode offers 1.0 CE hour for pharmacists and pharmacy technicians.
December 17, 2025
S9 E14: Immunotherapy and the MyMelanoma Project
Oxford’s Mark Middleton discusses how immunotherapy transformed melanoma outcomes, what researchers have learned along the way, and why projects like MyMelanoma are redefining real-world evidence.
December 10, 2025
S9 E13: A Season of Gratitude
Chuck Akanegbu, PharmD, shares how his PSO involvement and a surprise NMDP match turned into a lifesaving stem cell donation and a deeper commitment to oncology care.
November 25, 2025